Randomized Comparison of Sheaths for Radial Access (ACCESS-I)

August 12, 2016 updated by: Christian Juhl Terkelsen, Aarhus University Hospital Skejby

Randomized Comparison of Coated Slender Versus Un-coated Traditional Sheath

Coronary angiography (CAG) and possible angioplasty (Percutaneous Coronary Intervention = PCI) can be performed by access from the groin (a. femoralis), the wrist (a. radialis) or the elbow (a. brachialis). It is well established that there is less risk of bleeding complications when using a radial access. The smaller diameters of the vessels in the forearm, however, may result in increased risk of pain during CAG/PCI via a. radialis. This is associated with vascular spasm (spasm tendency). Ultimately this means that one may have to convert to access via a. femoralis.

To perform a CAG/PCI, a tube (a so-called sheath) has to be inserted in a. radialis. It is unclear whether the design of the sheaths can reduce the spasm tendency, thus reducing pain. Terumo has recently introduced a new kind of sheath, so-called Terumo Glide Slender Heath Coated (hereafter referred to as "Slender sheath"). This sheath is partly coated, partly made of a thinner material. "Slender sheath" thus has an outer diameter smaller than that of the sheath from traditional use (Terumo Radio Focus sheath, hereafter referred to as "Standard sheath"), although the inner diameter (lumen) is the same in the two sheaths. In turn, the "Slender sheath" is more fragile and far more expensive.

The purpose of the present study is to evaluate whether use of slender sheath compared with standard sheath is Associated with less pain and fewer complications following CAG/PCI.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Study design: Randomized study

Purposes: to investigate whether the use of "Slender sheath" is associated with less pain compared to use of "Standard Sheath" and less complications corresponding at the access site. Specific hypotheses:

  1. Use of "Slender sheath" results in less pain related to CAG/PCI compared to use of "Standard sheath".
  2. Use of "Slender sheath" is associated with fewer conversions to femoral access compared to use of "Standard sheath".
  3. Use of "Slender sheath" is associated with less use of analgesic during the procedure compared to use of "Standard sheath".
  4. Use of "Slender sheath" is associated with fewer cases of occlusion of a. radialis at discharge and post-examination compared to use of "Standard sheath".

Time Schedule The trial will run from December 2015 until a total number of 1000 patients are included. It is expected that the data collection and publication of the results will be completed within a year.

Endpoints

  1. Pain related to the application of the sheath (Visual Analog Scale = VAS)
  2. Maximal pain during CAG/PCI (VAS)
  3. Frequency of conversions to femoral access
  4. Use of analgesics (cumulative amount of mg Fentanyl given)
  5. Use of sedatives (cumulative amount of mg Midazolam given)
  6. Use of Verapamil (cumulative amount of mg given, used to reduce spasms)
  7. Number of catheters used
  8. Number of sheaths used (femoral and radial)
  9. Occlusion of a. radialis at the time of discharge estimated by ultrasound of the artery
  10. Occlusion of a. radialis after a month (Assumes that all patients with open vessels at discharge also have open vessels after a month. Only patients with occluded vessels at discharge will be offered a new ultrasound scan)

Study Type

Interventional

Enrollment (Actual)

1000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aarhus, Denmark, 8200
        • Department of cardiology, Aarhus University Hospital in Skejby

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All patients scheduled for radial angiography or angioplasty
  • Able to give written informed consent

Exclusion Criteria:

  • Negative Barbaue test or Allens test
  • Use of 8F catheters

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Slender arm
Uses the terumo slender sheath for radial angiography or angioplasty
Comparing outcomes for two different sheaths used during radial CAG/PCI
No Intervention: Standard arm
Uses the terumo standard sheath (Routine) for radial angiography or angioplasty

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain during sheath insertion
Time Frame: 1-2 minutes during sheath insertion
Maximal pain (Visual analogue scale) during sheath insertion
1-2 minutes during sheath insertion
Pain during the procedure
Time Frame: 10 minutes to 2 hours (during CAG/PCI)
Maximal pain (Visual analogue scale) during CAG/PCI
10 minutes to 2 hours (during CAG/PCI)
Proportion converted to femoral access
Time Frame: 10 minutes to 2 hours (during CAG/PCI)
Proportion of patients where the operator has to change to femoral access to complete the CAG/PCI
10 minutes to 2 hours (during CAG/PCI)
Use of analgesics, sedatives and verapamil during the procedure
Time Frame: 10 minutes to 2 hours (during CAG/PCI)
cumulative amount of analgesics, sedatives and verapamil during the procedure
10 minutes to 2 hours (during CAG/PCI)
Patency of a.radialis
Time Frame: Within one month of CAG/PCI
Ultrasound and reverse Barbaeu test is performed to test patency of a.radialis following CAG/PCI. If patency not documented at time of discharge the tests are repeated at one month. The artery is patent if normal Barbaue test and ultrasound without occlusion.
Within one month of CAG/PCI

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of catheters used
Time Frame: 10 minutes to 2 hours (during CAG/PCI)
cumulative number of catheters used during the procedure
10 minutes to 2 hours (during CAG/PCI)
Number of sheaths used
Time Frame: 10 minutes to 2 hours (during CAG/PCI)
cumulative number of sheaths used during the procedure
10 minutes to 2 hours (during CAG/PCI)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2015

Primary Completion (Actual)

July 1, 2016

Study Completion (Actual)

July 1, 2016

Study Registration Dates

First Submitted

December 16, 2015

First Submitted That Met QC Criteria

December 17, 2015

First Posted (Estimate)

December 22, 2015

Study Record Updates

Last Update Posted (Estimate)

August 16, 2016

Last Update Submitted That Met QC Criteria

August 12, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • ACCESS-I

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Radial Angiography

Clinical Trials on Slender Sheath

Subscribe